Reishi mushroom: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (Text replacement - "== References == <references />" to "== References == {{Reflist}}") |
Notjusttired (talk | contribs) m (Text replacement - " | first" to " | first") |
||
| (48 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
Reishi | '''Reishi''' or '''ganoderma lucidum''' or '''lingzhi''' is a mushroom of the Ganodermataceae family and contain much [[triterpene]], which works against [[inflammation]]. Reishi mushrooms have a similar effect to [[cortisone]] but help the body in a natural way.{{citation needed | date = Oct 2021}} | ||
Reishi activates and supports the [[immune system]] <ref>[https://doi.org/10.1002/chin.200650268 Ganoderma — A Therapeutic Fungal Biofactory]</ref>. | Reishi activates and supports the [[immune system]].<ref name="Paterson2006">[https://doi.org/10.1002/chin.200650268 Ganoderma — A Therapeutic Fungal Biofactory]</ref> Iwatsuki et al. (2013) found reishi inhibits the activation of [[Epstein-Barr virus]].<ref name="Iwatsuki2006">{{Cite journal | last = Iwatsuki | first = Kenji | author-link = | last2 = Akihisa | first2 = Toshihiro | authorlink2 = | last3 = Tokuda | first3 = Harukuni | authorlink3 = | last4 = Ukiya | first4 = Motohiko | authorlink4 = | last5 = Oshikubo | first5 = Manabu | authorlink5 = | last6 = Kimura | first6 = Yumiko | authorlink6 = | last7 = Asano | first7 = Takeshi | last8 = Nomura | first8 = Atsushi | last9 = Nishino | first9 = Hoyoku | date = Dec 2003 | title = Lucidenic acids P and Q, methyl lucidenate P, and other triterpenoids from the fungus Ganoderma lucidum and their inhibitory effects on Epstein-Barr virus activation|url=https://pubmed.ncbi.nlm.nih.gov/14695801/|journal=Journal of Natural Products|volume=66|issue=12|pages=1582–1585|doi=10.1021/np0302293|issn=0163-3864|pmc=|pmid=14695801|access-date=|quote=|via=}}</ref> | ||
== | ==ME/CFS== | ||
It is used in the treatment regime against ME of Ms Voss to prevent the use of [[Raltegravir]]. | ==Evidence== | ||
It is used in the treatment regime against ME of Ms [[Katrina Voss]] to prevent the use of [[Raltegravir]]. | |||
*[http://meversuscfs.blogspot.com/2018/06/arztanfragen-mein-therapieregime-fur.html My antiretroviral Regime for Antiretroviral Treatment of Myalgic Encephalomyelitis (Deutsch: #Arztanfragen - Mein Therapieregime für die antiretrovirale Behandlung bei Myalgischer Enzephalomyelitis)] | *[http://meversuscfs.blogspot.com/2018/06/arztanfragen-mein-therapieregime-fur.html My antiretroviral Regime for Antiretroviral Treatment of Myalgic Encephalomyelitis (Deutsch: #Arztanfragen - Mein Therapieregime für die antiretrovirale Behandlung bei Myalgischer Enzephalomyelitis)] | ||
A small trial by Soksawatmakhin et al. (2013) found that a dose of 500mg or reishi extract four times per day resulted in a clinically significant improvement in patients with unexplained chronic fatigue meeting the [[NICE guidelines]] criteria for CFS/ME.<ref name="Soksawatmakhin2013" /> | |||
==Notable studies == | |||
*2013, Preliminary study of the applications of Ganoderma lucidum in chronic fatigue syndrome<ref name="Soksawatmakhin2013">{{Cite journal | last = Soksawatmakhin | first = Sukanya | author-link = | last2 = Boonyahotra | first2 = Wijit | author-link2 = | date = Jan 2013 | title = Preliminary study of the applications of Ganoderma lucidum in chronic fatigue syndrome|url=http://www.aaspjournal.org/abstract.php?article_id=5940|journal=Journal of Asian Association of Schools of Pharmacy|language=en|volume=2|issue=|pages=262–268|doi=|issn=0975-6299|pmc=|pmid=|access-date=|quote=|via=}}</ref>[https://www.aaspjournal.org/uploads/155/5940_pdf.pdf (Full text)] | |||
==Learn more == | |||
*[https://www.webmd.com/vitamins-and-supplements/reishi-mushroom-uses-and-risks Reishi mushroom: uses and risks] - WebMD | |||
*[https://www.eneksia.com/ganoderma-lucidum Gandoderma] - Longevis | |||
==See also == | |||
*[[Maitake mushroom]] | |||
*[[Shiitake mushroom]] | |||
*[[Longevis]] | |||
== References == | == References == | ||
| Line 13: | Line 26: | ||
[[Category:Potential treatments]] | [[Category:Potential treatments]] | ||
[[Category:Medicinal foods]] | |||
[[Category:Supplements]] | |||
[[Category:Alternative medicine]] | |||
[[Category:Traditional Chinese medicine]] | |||
Latest revision as of 16:26, April 3, 2023
Reishi or ganoderma lucidum or lingzhi is a mushroom of the Ganodermataceae family and contain much triterpene, which works against inflammation. Reishi mushrooms have a similar effect to cortisone but help the body in a natural way.[citation needed] Reishi activates and supports the immune system.[1] Iwatsuki et al. (2013) found reishi inhibits the activation of Epstein-Barr virus.[2]
ME/CFS[edit | edit source]
Evidence[edit | edit source]
It is used in the treatment regime against ME of Ms Katrina Voss to prevent the use of Raltegravir.
A small trial by Soksawatmakhin et al. (2013) found that a dose of 500mg or reishi extract four times per day resulted in a clinically significant improvement in patients with unexplained chronic fatigue meeting the NICE guidelines criteria for CFS/ME.[3]
Notable studies[edit | edit source]
- 2013, Preliminary study of the applications of Ganoderma lucidum in chronic fatigue syndrome[3](Full text)
Learn more[edit | edit source]
- Reishi mushroom: uses and risks - WebMD
- Gandoderma - Longevis
See also[edit | edit source]
References[edit | edit source]
- ↑ Ganoderma — A Therapeutic Fungal Biofactory
- ↑ Iwatsuki, Kenji; Akihisa, Toshihiro; Tokuda, Harukuni; Ukiya, Motohiko; Oshikubo, Manabu; Kimura, Yumiko; Asano, Takeshi; Nomura, Atsushi; Nishino, Hoyoku (December 2003). "Lucidenic acids P and Q, methyl lucidenate P, and other triterpenoids from the fungus Ganoderma lucidum and their inhibitory effects on Epstein-Barr virus activation". Journal of Natural Products. 66 (12): 1582–1585. doi:10.1021/np0302293. ISSN 0163-3864. PMID 14695801.
- ↑ 3.0 3.1 Soksawatmakhin, Sukanya; Boonyahotra, Wijit (January 2013). "Preliminary study of the applications of Ganoderma lucidum in chronic fatigue syndrome". Journal of Asian Association of Schools of Pharmacy. 2: 262–268. ISSN 0975-6299.
